Preterm Multigravida with IUGR in Severe Preeclampsia: A Case Report
DOI:
https://doi.org/10.53089/medula.v12i2.409Keywords:
Preterm,Intrauterine growth retriction,PreeclampsiaAbstract
Intrauterine growth restriction (IUGR) is a baby born at term but has a low birth weight (LBW) due to impaired fetal growth while in the mother's womb. Intrauterine growth restriction (IUGR) is closely related to severe preeclampsia (PEB). In PEB there is interference with placental implantation, thereby reducing blood flow to the fetus. Reduced blood flow causes inadequate nutrition for fetal growth. Intrauterine growth restriction (IUGR) is a fairly common complication, where the prevalence reaches 3-7% of all pregnancies in developing countries. This study is a case report where Mrs. Ni, 41 years old with G3P2A0 34 weeks pregnant came to PONEK with clear discharge and heartburn up to the waist. On the os, it was found that the conjunctiva was anemic and the height of the uterine fundus did not match the gestational age. Laboratory examinations showed hemoglobin 10.4 g/dL, Hematocrit 32%, erythrocytes 3.7 million/ul, proteinuria ++. Based on the data above, the patient was diagnosed as Mrs. Ni, G3P2A0, 41 years old, 34 weeks gestation, single live fetus, intrauterine, breech presentation, right back, not yet inpartu with IUGR.
References
Awamleh Z, Gloor GB, Han VK. Placental microRNAs in pregnancies with early onset intrauterine growth restriction and preeclampsia: potential impact on gene expression and pathophysiology. BMC Med Genomics. 2019;12(1):1-10.
Huppertz B. The critical role of abnormal trophoblast development in the etiology of preeclampsia. Curr Pharm Biotechnol. 2018;19(10):771-780.
Alisjahbana B, Rivami DS, Octavia L, et al. Intrauterine growth retardation (IUGR) as determinant and environment as modulator of infant mortality and morbidity: the Tanjungsari Cohort Study in Indonesia. Asia Pac J Clin Nutr. 2019;28(Supplement 1).
Duhig KE, Myers J, Seed PT, et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. The Lancet. 2019;393(10183):1807-1818.
Kwiatkowski S, Kwiatkowska E, Torbe A. The role of disordered angiogenesis tissue markers (sflt-1, Plgf) in present day diagnosis of preeclampsia. Ginekol Pol. 2019;90(3):173-176.
Kesavan K, Devaskar SU. Intrauterine growth restriction: postnatal monitoring and outcomes. Pediatr Clin. 2019;66(2):403-423.
Oskovi Kaplan ZA, Ozgu-Erdinc AS. Prediction of preterm birth: maternal characteristics, ultrasound markers, and biomarkers: an updated overview. J Pregnancy. 2018;2018.
McCowan LM, Figueras F, Anderson NH. Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy. Am J Obstet Gynecol. 2018;218(2):S855-S868.
Formanowicz D, Malińska A, Nowicki M, et al. Preeclampsia with intrauterine growth restriction generates morphological changes in endothelial cells associated with mitochondrial swelling—an in vitro study. J Clin Med. 2019;8(11):1994.
Zainiyah Z. Relationship Between Parity And Gestational Age With The Incidence Of Preeclampsi In Rsud Syarifah Ambami Rato Ebhu Bangkalan. J Ilm OBSGIN J Ilm Ilmu Kebidanan Kandung P-ISSN 1979-3340 E-ISSN 2685-7987. 2021;13(1):20-23.
Menendez-Castro C, Rascher W, Hartner A. Intrauterine growth restriction-impact on cardiovascular diseases later in life. Mol Cell Pediatr. 2018;5(1):1-3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
